Step 02: ALS Reversal Science

Summary of this Step

• Healing ALS encourages review of peer-reviewed research referenced on its website, including studies documenting atypical ALS disease courses. The very bottom of this page lists a dozen peer-reviewed articles verifying the science behind ALS reversals.
• A 2024 observational study of 45 ALS patients participating in Healing ALS programs reported, over 12 months, that ~20% improved on the ALSFRS-R score, ~20% stabilized, and ~20% declined by only 1–4 points (compared to an average annual decline of ~12 points).
• Healing ALS is currentluy recruiting for a 1,000-person ALS observational study (HAROS) which will benefit those currently with ALS.
• Study findings have been presented at major neurology and medical conferences, including the American Neurological Association, American Academy of Neurology, ALS/MND World Congress, and the Institute for Functional Medicine.
• Peer-reviewed research in (2018) documented 34 medically verified ALS reversals
• As of January 2026 over 60 ALS reversals have been medically documented.
• These reversals were independently verified; Healing ALS is not affiliated with any of the Universities or Institutions involved in the study.
• Educational videos, patient presentations, and integrative medicine frameworks are shared to promote hope, awareness, and a broader view of ALS management beyond symptom-focused care.

1. Read through the references of the Peer Reviewed articles at the bottom of this page

• See references at bottom of this page.

2. Healing ALS is currently recruiting for a 1000 person ALS observational Study.

• US Residents: Click here for Details on How to Participate in the study
• All other residents: Click here to join the Healing ALS registry and put your data in monthly so you and others with ALS can benefit from our findings.

3. 2024 Observational study of 45 ALS Patients

2024 Study Results:

Of ALS Patients who regularly participated in Healing ALS Programs, over a 12 month period, on average:

• 20% reversed ALS symptoms on the ALSFRS-R Score
• 20% stablilized ALS symptoms on the ALSFRS-R Score.
• 20% lost only 1-4 points on the ALSFRS-R Score (average loss is 12 points).

Click here for the current Observational study (HAROS) NOW RECRUITING and the 2024 Observational study results

4. Healing ALS Presenting at ALS and Neurological Conferences

Our medical team has presented findings at the following conferences:

• Institute for Functional Medicine (Annual World Conference 2025)
• American Academy of Neurology (Annual Conference 2025)
• ALS/MND World Congress (Annual Conference 2024)
• American Neurological Association (Regional conference 2024)
• American Neurological Association (Annual conference 2024)

5. Peer Reviewed Study and ALS Reversal Documentation

• Open a few of the peer reviewed research articles in the References section, at the bottom of this Step (Step 2).
• Read the abstracts from a few of them.
• Skim or read this article in full: <<<CLICK HERE>>> 2018 published peer-reviewed journal article by a team of University reserachers when they medically documented 34 ALS reversals.
• As of January 2026, researchers have documented over 60 ALS reversals.
• Please remember that these researchers did not help any of these people reverse their symptoms. They verified their ALS diagnosis and their reversal of symptoms.
• The PALS themselves reversed ALS working on their own doing a variety of protocols including doing their own research, following their intuition, and consulting with medical professionals.
• Healing ALS is not affiliated with any of the universities, institutions nor with any of the authors of this paper. This is independent verification of many of the ALS reversals that Healing ALS has identified.

6. Watch Video for understanding the science of why ALS is reversible

The following interview is with a board certified neurologist and Director of the ALS Clinic at Duke University who has been documenting ALS reversals, Dr. Richard Bedlack, MD, PhD. He has publicly stated recently that his team has verified over 60 ALS Reversals. Healing ALS is not affiliated with Dr. Bedlack. This is independent verification of many of the ALS Reversals that Healing ALS has identified.

7. Go to HealingALS.org Recordings (Events – Past Recordings). (You need to be a member to see this page). Watch the main presentations of the following 3 weeks (you can skip Q&A if you like) of:

• Sept 12, 2021 New Season 4 ALS Reversals Part 1
  Note Name, diagnosis date and something about each person that you think helped them reverse ALS
• Sept 19, 2021 New Season 4 ALS Reversals Part 2
  Note Name, diagnosis date and something about each person that you think helped them reverse ALS
• Sept 26, 2021 New Season 4 ALS Reversals Part 3
  Note Name, diagnosis date and something about each person that you think helped them reverse ALS

---

We hope after reading and watching the above content that you can recognize amyotrophic lateral sclerosis ALS symptoms, and know that with the right treatments and measures, your life expectancy with an ALS or MND diagnosis can be improved.
A diagnosis of ALS disease and a neurogenerative condition is not a death sentence.

8. Review Difference between Conventional Medicine and Integrative/Functional Medicine

Conventional Medicine

• Treats symptoms
• Focuses on diagnosing and treating disease
• Uses pharmaceutical drugs, surgery and technology

Integrative Medicine

• Combines conventional treatments with evidence-based holistic, and lifestyle-focused treatments
• Therapies include: nutrition, acupuncture, safe detoxification, stress management, meditation, frequency therapies
• Addresses root cause of illness
• Treats the whole person

9. Review in Quick Start: Why does my neurologist not know about this approach or dismiss it?

• 7 Day Quick Start – Healing ALS

10. Inspirational Video for Today

• https://www.youtube.com/watch?v=nd74h_UjUmw

2023: Click Here to View The Recording of Step 2

Check for Understanding and Completion of Step 2:

I have looked over the results of the 2024 observational study of 45 PALS over 12 months.

I have reviewed the conferences at which Healing ALS medical professionals have presented.

I have reviewed the scientific references at the bottom of this Step (Step 2).

I watched the video of ALS Reversals presented Dr. Richard Bedlack, MD, PhD from Duke University.

I understand that Dr. Bedlack is not trained in functional or integrative medicine and has no ALS reversals of his own.

I understand that Dr Bedlack is not affiliated with Healing ALS.

Write down the difference between a conventional doctor and a functional/Integrative doctor.

I have watched the September 12, 2021 Sunday Recording and written down something about each person that I think helped them reverse ALS.

I have watched the September 19, 2021 Sunday Recording and written down something about each person that I think helped them reverse ALS.

I have watched the September 26, 2021 Sunday Recording and written down something about each person that I think helped them reverse ALS.

I continue to write down at least 3 gratitudes each day and a best moment (either from the past 24 hours or anytime in the past).

If you have checked all boxes, Congratulations! You have completed Step 2!

References

1. Total Reversal of ALS Confirmed by EMG Normalization, Structural
   Reconstitution, and Neuromuscular-Molecular Restoration Achieved
   Through Computerized Brain-Guided Reengineering of the 1927 Nobel
   Prize Fever Therapy: A Case Report M Marc Abreu, Mohammad Hosseine-
   Farid, David G Silverman. Diseases. 2025 Nov 12;13(11):371. doi:
   10.3390/diseases13110371. https://pubmed.ncbi.nlm.nih.gov/41294911/
2. Plateaus and reversals evaluated by different methods in patients with
   limb-onset amyotrophic lateral sclerosis Nan Hu, Dongchao Shen, Xunzhe
   Yang, Liying Cui,  Mingsheng Liu . J Clin Neurosci . 2022 Mar:97:93-98. doi:
   10.1016/j.jocn.2022.01.016. Epub 2022 Jan 21.
   https://europepmc.org/article/MED/35074582
3. In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis: An Updated
   Overview. AuderlanM. Gois, Deise M.F. Mednonca, et al. Brain Research
   Bulletin Vol 159, 2020: 32-43
   https://www.sciencedirect.com/science/article/pii/S0361923019308810
4. NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic
   Lateral Sclerosis. Obrador E, Salvador-Palmer R, et al. 2021 Aug 1
   Biomedicines. Doi:10.3390/biomedicines9081000. PMID: 34440204.
   https://pmc.ncbi.nlm.nih.gov/articles/PMC8394119/
5. Abreu MM, Hosseine-Farid M, Silverman DG. Total Reversal of ALS Confirmed by EMG Normalization, Structural Reconstitution, and Neuromuscular-Molecular Restoration Achieved Through Computerized Brain-Guided Reengineering of the 1927 Nobel Prize Fever Therapy: A Case Report. Diseases. 2025 Nov 12;13(11):371. doi: 10.3390/diseases13110371. PMID: 41294911; PMCID: PMC12651036.
6. Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Rodal I, Carrasco L . Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int J Biol Sci. 2015 11(5):546-58. doi: 10.7150/ijbs.11084. Epub 2015 Apr 02.
7. Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, Macklin EA, Schoenfeld D, Cudkowicz M, Sherman A. How common are ALS plateaus and reversals? Neurology. 2016 Mar 1;86(9):808-12. doi: 10.1212/WNL.0000000000002251. Epub 2015 Dec 9. PMID: 26658909; PMCID: PMC4793781.
8. Boddy SL, Giovannelli I, Sassani M, Cooper-Knock J, Snyder MP, Segal E, Elinav E, Barker LA, Shaw PJ, McDermott CJ . The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med. 2021 Jan;19(1):13. doi: 10.1186/s12916-020-01885-3. Epub 2021 Jan 20.
9. Bond L, Ganguly P, Khamankar N, Mallet N, Bowen G, Green B, Mitchell CS. A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes. Brain Sci. 2019 Sep 4;9(9):223. doi: 10.3390/brainsci9090223.
10. Crayle J, Lutz M, Raymond J, Mehta P, Bedlack R. Study of “ALS reversals”: LifeTime environmental exposures (StARLiTE). Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):54-62. doi: 10.1080/21678421.2022.2090846. Epub 2022 Jul 1.
11. Diana Noland, Rhett Bergeron, & Larisa Syrow. (2025). Case Study on ALS Reversal: An Integrative Medicine Approach to Sporadic Limb-Onset ALS (P12-11.018). Neurology, 104.
12. Filippini T, Tesauro M, Fiore M, Malagoli C, Consonni M, Violi F, Iacuzio L, Arcolin E, Oliveri Conti G, Cristaldi A, Zuccarello P, Zucchi E, Mazzini L, Pisano F, Gagliardi I, Patti F, Mandrioli J, Ferrante M, Vinceti M . Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int J Environ Res Public Health. 2020 Apr;17(8):doi: 10.3390/ijerph17082882. Epub 2020 Apr 22.
13. Fiore M, Parisio R, Filippini T, Mantione V, Platania A, Odone A, Signorelli C, Pietrini V, Mandrioli J, Teggi S, Costanzini S, Antonio C, Zuccarello P, Oliveri Conti G, Nicoletti A, Zappia M, Vinceti M, Ferrante M. Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study. Environ Res. 2020 Jul;186:109530. doi: 10.1016/j.envres.2020.109530. Epub 2020 Apr 15.
14. Floeter MK, Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):339-46. doi: 10.3109/17482960903171136.
15. Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, van den Berg LH, Crayle J, Bedlack R; Pooled Resource Open-Access ALS Clinical Trials Consortium. “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):495-499. doi: 10.1080/21678421.2018.1457059. Epub 2018 Apr 2. PMID: 29607695.
16. Li JY, Sun XH, Cai ZY, Shen DC, Yang XZ, Liu MS, Cui LY. Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Sci Rep. 2022 Aug 2;12(1):13292. doi: 10.1038/s41598-022-16229-9.
17. Noor Eddin, A., Alfuwais, M., Noor Eddin, R., Alkattan, K., & Yaqinuddin, A. (2024). Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives. Nutrients, 16(5), 590. https://doi.org/10.3390/nu16050590
18. Peters S, Broberg K, Gallo V, Levi M, Kippler M, Vineis P, Veldink J, van den Berg L, Middleton L, Travis RC, Bergmann MM, Palli D, Grioni S, Tumino R, Elbaz A, Vlaar T, Mancini F, Kühn T, Katzke V, Agudo A, Goñi F, Gómez JH, Rodríguez-Barranco M, Merino S, Barricarte A, Trichopoulou A, Jenab M, Weiderpass E, Vermeulen R . Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort. Ann Neurol. 2021 Jan;89(1):125-133. doi: 10.1002/ana.25932. Epub 2020 Nov 06.
19. Sales de Campos P, Olsen WL, Wymer JP, Smith BK. Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review. Chron Respir Dis. 2023 Jan-Dec;20:14799731231175915. doi: 10.1177/14799731231175915.
20. Syrow L, Calderwood D, Newton C; An Integrative Medicine approach may slow disease in ALS patients compared to standard of care: A pilot observational study. Annals of Neurology Volume 96, Number S32, 149th Annual Meeting American Neurological Association pp. S278-279 (September 2024) https://onlinelibrary.wiley.com/doi/10.1002/ana.27051

The information we share is for educational purposes and should not be treated as medical advice.

© Copyright Healing Advocates Registry and Ministry